Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$278M |
| 2 |
Exxon Mobil
XOM
|
+$270M |
| 3 |
Verizon
VZ
|
+$141M |
| 4 |
Yum China
YUMC
|
+$135M |
| 5 |
Chevron
CVX
|
+$122M |
Top Sells
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.29% |
| 3 | Industrials | 12.37% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
3126
DELISTED
AlerisLife Inc. Common Stock
ALR
| $345K | ﹤0.01% |
363,223
-44,273
| -11% | -$42.1K |
|
|
PRVB
3127
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $344K | ﹤0.01% |
76,581
-3,461
| -4% | -$15.5K |
|
3128
Kingsway Financial Services
KFS
$407M
| $343K | ﹤0.01% |
49,538
| – | – |
|
3129
TIM SA
TIMB
$10B
| $343K | ﹤0.01% |
30,761
-206
| -0.7% | -$2.3K |
|
|
VIOT
3130
Viomi Technology
VIOT
$226M
| $342K | ﹤0.01% |
277,638
-23,402
| -8% | -$28.8K |
|
3131
Ring Energy
REI
$215M
| $341K | ﹤0.01% |
146,899
-9,145
| -6% | -$21.2K |
|
|
ITOS
3132
DELISTED
iTeos Therapeutics
ITOS
| $340K | ﹤0.01% |
17,874
| – | – |
|
3133
CKX Lands
CKX
$22.8M
| $339K | ﹤0.01% |
31,018
+122
| +0.4% | +$1.33K |
|
3134
Marchex
MCHX
$88.4M
| $339K | ﹤0.01% |
202,219
+16,111
| +9% | +$27K |
|
3135
Synchronoss Technologies
SNCR
$62.8M
| $337K | ﹤0.01% |
32,825
-29,812
| -48% | -$306K |
|
3136
Rallybio
RLYB
$25.1M
| $335K | ﹤0.01% |
+23,166
| New | +$335K |
|
3137
Lindblad Expeditions
LIND
$717M
| $333K | ﹤0.01% |
49,210
-23,611
| -32% | -$160K |
|
3138
Pathfinder Bancorp
PBHC
$92.8M
| $333K | ﹤0.01% |
16,382
+746
| +5% | +$15.2K |
|
3139
Lake Shore Bancorp
LSBK
$102M
| $331K | ﹤0.01% |
25,171
+11
| +0% | +$145 |
|
3140
Scholar Rock
SRRK
$3B
| $329K | ﹤0.01% |
47,389
-116,797
| -71% | -$811K |
|
3141
Zevra Therapeutics
ZVRA
$448M
| $329K | ﹤0.01% |
52,722
+1,064
| +2% | +$6.64K |
|
3142
Coda Octopus Group
CODA
$88.8M
| $325K | ﹤0.01% |
60,227
+7,243
| +14% | +$39.1K |
|
|
FORTY
3143
Formula Systems
FORTY
$2.22B
| $325K | ﹤0.01% |
4,017
+19
| +0.5% | +$1.54K |
|
|
IVC
3144
DELISTED
Invacare Corporation
IVC
| $325K | ﹤0.01% |
416,183
-531,424
| -56% | -$415K |
|
3145
Instil Bio
TIL
$155M
| $322K | ﹤0.01% |
3,312
+2,001
| +153% | +$195K |
|
3146
Q32 Bio
QTTB
$21.7M
| $320K | ﹤0.01% |
11,029
-489
| -4% | -$14.2K |
|
|
WMPN
3147
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $320K | ﹤0.01% |
28,177
+5,153
| +22% | +$58.5K |
|
3148
Personalis
PSNL
$478M
| $319K | ﹤0.01% |
107,404
-58,632
| -35% | -$174K |
|
|
SGMA
3149
DELISTED
Sigmatron International
SGMA
| $319K | ﹤0.01% |
67,207
-2,062
| -3% | -$9.79K |
|
3150
Neuronetics
STIM
$228M
| $319K | ﹤0.01% |
100,781
+71,765
| +247% | +$227K |
|